RankAlpha logo
Back to Rankings

UNCY

Unicycive TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
UNCY vs peer average
76/100
UNCY vs. peer average (B vs. D)
Grade spread
A 1 · C 3 · D 4 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

AKBA is the first available peer comparator.

Akebia is another direct comparator because Auryxia is named in Unicycive's 10-K as a competing phosphate binder, giving a practical reference point for nephrology commercialization and reimbursement dynamics.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAKBAAkebia Therapeutics
UNCY
Unicycive Therapeutics
AKBA
Akebia Therapeutics
Grade
B
D
Momentum
79
16
Value
41
66
Sentiment
55
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs AKBA

UNCY / AKBA
Grade Position
Above peers
UNCY vs. peer average (B vs. D)
76/100
Momentum
79
UNCY
Value
41
AKBA
Sentiment
55
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs UNCY
1
AKBA
AKBA
D
40/100
+2
2
ARDX
ARDX
C
60/100
+1
3
FMS
FMS
F
20/100
+3
4
IMDX
Insight Molecular Diagnostics Inc Common
C
60/100
+1
5
ANIK
Anika Therapeutics Inc Common
A
100/100
-1
AKBA is the first peer returned for this comparison set.